JAMES COMBS: Open Payments
NPI 1265455331 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 42 payments from 22 companies in 2025. Trend: 2023 $1,313 · 2024 $1,347 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $66 |
| Radius Health, Inc. | 3 | $66 |
| ABBVIE INC. | 4 | $64 |
| Lilly USA, LLC | 4 | $63 |
| Dexcom, Inc. | 3 | $61 |
| PFIZER INC. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Cleerly, Inc. | 1 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
Products named: Veozah, Tymlos, Dexcom G6 Transmitter, MOUNJARO, Cleerly Ischemia, NURTEC ODT, GARDASIL 9, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
